comparemela.com

Latest Breaking News On - Marion janic - Page 1 : comparemela.com

Investegate |NuCana plc Announcements | NuCana plc: NuCana Reports Third Quarter 2022 Financial Results and Provides Business Update

Investegate announcements from NuCana plc, NuCana Reports Third Quarter 2022 Financial Results and Provides Business Update

United kingdomCity ofHughs griffithMarion janicChris brinzeyCompany annual report on formExchange commissionEuropean society of medical oncologyNucana reports third quarterProvides businessData readoutsFirst halfAnticipated cash runwayChief executiveEuropean societyMedical oncology

NuCana plc: NuCana Reports Third Quarter 2022 Financial Results and Provides Business Update

Multiple Data Readouts on Track for the Remainder of 2022 and the First Half of 2023 Well Capitalized with Anticipated Cash Runway into 2025 EDINBURGH, United Kingdom, Nov. 16, 2022 (GLOBE NEWSWIRE)

United kingdomCity ofHughs griffithMarion janicChris brinzeyCompany annual report on formExchange commissionEuropean society of medical oncologyMultiple data readoutsFirst halfAnticipated cash runwayChief executiveEuropean societyMedical oncologyAnnual meetingPrivate securities litigation reform act

Investegate |NuCana plc Announcements | NuCana plc: NuCana to Present at the Jefferies London Healthcare Conference

Investegate announcements from NuCana plc, NuCana to Present at the Jefferies London Healthcare Conference

United kingdomCity ofDon munozHughs griffithHugh griffithMarion janicChris brinzeyExchange commissionCompany annual report on formJefferies london healthcareChief executive officerChief financial officerPrivate securities litigation reform actAnnual reportInvestegate announcementsInvestegate company announcements

NuCana plc: NuCana to Present at the Jefferies London Healthcare Conference

EDINBURGH, United Kingdom, Nov. 08, 2022 (GLOBE NEWSWIRE) NuCana plc (NASDAQ: NCNA) announced today that Hugh Griffith, Chief Executive Officer, and Don Munoz, Chief Financial Officer, will present

United kingdomCity ofDon munozHughs griffithHugh griffithMarion janicChris brinzeyExchange commissionCompany annual report on formChief executive officerChief financial officerJefferies london healthcarePrivate securities litigation reform actAnnual report

NuCana plc: NuCana Presents Positive Data on NUC-3373 at the 34th EORTC-NCI-AACR Annual Meeting 2022

NUC-3373 Potentiates Immunogenic Activity in Lung Cancer Cells Pembrolizumab Activity Increased by NUC-3373 in Lung Cancer Cells NuCana has Initiated the NuTide:303 Study of NUC-3373 in Combination

Comunidad autonoma de catalunaHughs griffithMarion janicChris brinzeyCompany annual report on formExchange commissionImmunogenic activityLung cancerActivity increasedChief executive officerPrivate securities litigation reform actAnnual report

vimarsana © 2020. All Rights Reserved.